Cost-effectiveness of harm reduction in preventing hepatitis C among injection drug users.

@article{Pollack2001CosteffectivenessOH,
  title={Cost-effectiveness of harm reduction in preventing hepatitis C among injection drug users.},
  author={Harold A. Pollack},
  journal={Medical decision making : an international journal of the Society for Medical Decision Making},
  year={2001},
  volume={21 5},
  pages={357-67}
}
OBJECTIVES Hepatitis C (HCV) has emerged as a major epidemic among injection drug users (IDUs), with observed prevalence exceeding 70% in many American and European cities. This article explores the potential of syringe exchange programs (SEPs) to reduce HCV incidence and prevalence. DESIGN A random-mixing epidemiological model is used to examine the potential impact of harm reduction interventions. METHODS Steady-state analysis is used to scrutinize the impact of SEP on HCV incidence and… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 25 extracted citations

Similar Papers

Loading similar papers…